Ms Jennifer Edith James, LCSW | |
814 E. Bamberger Drive Suite B, Psychological Assessment & Treatment Specialists, Inc., American Fork, UT 84003 | |
(801) 772-0202 | |
(801) 772-0139 |
Full Name | Ms Jennifer Edith James |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 814 E. Bamberger Drive Suite B, American Fork, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720131899 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Ms Jennifer Edith James, LCSW 814 E. Bamberger Drive Suite B, Psychological Assessment & Treatment Specialists, Inc., American Fork, UT 84003 Ph: (801) 772-0202 | Ms Jennifer Edith James, LCSW 814 E. Bamberger Drive Suite B, Psychological Assessment & Treatment Specialists, Inc., American Fork, UT 84003 Ph: (801) 772-0202 |
News Archive
Princeton Instruments and the Center for Structured Organic Particulate Systems are pleased to announce a six-month collaboration on a novel pharmaceutical technology that enables close monitoring and control of drug manufacturing processes.
In a potentially precedent-setting ruling, the Washington State Supreme Court determined last week that psychiatric boarding — the process by which patients are admitted to a hospital, but remain in the emergency department for hours, even days, until psychiatric beds become available — is unconstitutional and violates the state's Involuntary Treatment Act.
Recent research by doctoral student Sevan Goenezen holds the promise of becoming a powerful new weapon in the fight against breast cancer. His complex computational research has led to a fast, inexpensive new method for using ultrasound and advanced algorithms to differentiate between benign and malignant tumors with a high degree of accuracy.
Accumulation of the substance amyloid beta in the brain impairs the memory and cognitive ability in people with Alzheimer's. New findings from Lund University in Sweden show that the cause of amyloid beta pathology might be more versatile than previously known. Researchers believe that these new findings may be of significance to the development of new medications.
› Verified 9 days ago